Showing 1 posts of 1 posts found.
GlaxoSmithKline has been found guilty of two transgressions of the ABPI Code of Practice in a case centring on the …
Long-acting therapies set to reshape HIV treatment market
MHRA authorises Lynkuet for hot flushes linked to breast cancer therapy
MHRA approves Romvimza for tenosynovial giant cell tumour
NICE recommends allergy immunotherapy tablets for younger children
Dunbar Pharmaceuticals and IPS Pharma announce distribution agreement